-
Nilgün Altuntas,
Idil Yenicesu,
Ozdemir Himmetoglu,
Ferit Kulali,
Ebru Kazanci,
Sezin Unal,
Selma Aktas,
Ibrahim Hirfanoglu,
Esra Onal,
Canan Turkyilmaz,
Ebru Ergenekon,
Esin Koc,
Yıldız Atalay
[show abstract]
[hide abstract]
ABSTRACT: Maternal red-cell alloimmunization occurs when a woman's immune system is sensitized to foreign red-blood cell surface antigens, leading to the production of alloantibodies. The resulting antibodies often cross the placenta during pregnancies in sensitized women and, if the fetus is positive for red-blood-cell surface antigens, this will lead to hemolysis of fetal red-blood cells and anemia. The most severe cases of hemolytic disease in the fetus and newborn baby are caused by anti-D, anti-c, anti-E and anti-K antibodies. There are limited data available on immunization rates in pregnant women from Turkey. The aim of the present study was to provide data on the frequency and nature of maternal RBC alloimmunization in pregnant women in a tertiary care hospital. In this study, we retrospectively evaluated the indirect antiglobulin test results of Rh-negative pregnant women performed in our Blood Bank between 2006 and 2012. Indirect antiglobulin test positive women also underwent confirmatory antibody screening and identification. During the study period, 4840 women admitted to our antenatal clinics. With regards to the major blood group systems (ABO and Rh), the most common phenotype was O positive (38.67%). There were 4097 D-antigen-positive women (84.65%) and 743 women with D-antigen-negative phenotype (15.35%). The prevalence of alloimmunization was found to be 8.74% in D-antigen negative group. Despite prophylactic use of Rh immunglobulins, anti-D is still a common antibody identified as the major cause of alloimmunization in our study (anti-D antibody 68.57%, non-D antibody 31.42%). While alloimmunization rate to D antigen was 6.46%, non-D alloimmunization rate was 2.69% among Rh-negative pregnant women. Moreover, detailed identification facilities for antibodies other than anti-D are not available in most of centers across Turkey. However, large-scale studies on pregnant women need to be done in order to collect sufficient evidence to formulate guidelines and to define indications for alloantibody screening and identification.
Transfusion and Apheresis Science 04/2013; · 1.25 Impact Factor
-
Nilgün Altuntas,
Idil Yenicesu,
Serdar Beken,
Ferit Kulali,
Fatma Burcu Belen,
Ibrahim Murat Hirfanoglu,
Esra Onal,
Canan Turkyilmaz,
Ebru Ergenekon,
Esin Koc,
Yıldız Atalay
[show abstract]
[hide abstract]
ABSTRACT: Recommendations for FFP use in neonates are based on a very limited amount of data, and not on well-designed randomized controlled trials. This retrospective study was performed to analyze our experience with FFP use in neonatal intensive care unit (NICU). From January 2006 until August 2011 a total of 80 neonates were identified as having been treated with FFP. The most common indication for FFP use was prolonged PT or aPTT, representing 32.8% of all usages of FFP. Following FFT treatment PT and aPTT normalized in 42% and 60% patients, respectively. Our results suggest that FFP were often used in acceptable indications in NICU.
Transfusion and Apheresis Science 05/2012; 47(1):91-4. · 1.25 Impact Factor
-
Kıvılcım Gucuyener,
Serdar Beken,
Ebru Ergenekon,
Sebnem Soysal,
Ibrahim Hirfanoglu,
Ozden Turan,
Sezin Unal, Nilgün Altuntas,
Ebru Kazanci,
Ferit Kulali,
Esin Koc,
Canan Turkyilmaz,
Esra Onal,
Yıldız Atalay
[show abstract]
[hide abstract]
ABSTRACT: Amplitude-integrated electroencephalogram (aEEG) at <6 h is the best single outcome predictor in term infants with perinatal asphyxia at normothermia. Hypothermia treatment has changed the cutoff values for outcome prediction by using time at onset of normal trace and SWC. Cerebral hemodynamics and oxygenation changes detected by near infrared spectroscopy (NIRS) during hypothermia treatment in aphyxiated neonates are not a well known issue.
The aim of this study was to investigate the correlations between brain monitoring (amplitude integrated EEG and NIRS) and outcome in asphyxiated full-term infants with moderate/severe hypoxic-ischemic encephalopathy before, during and after hypothermia treatment.
Ten neonates were recruited for hypothermia treatment by using the cool cap entry criteria. aEEG and NIRS were applied in 10 and 8 patients, respectively with moderate and severe hypoxic-ischemic encephalopathy before, just after brain cooling and rewarming periods. Patterns and voltages of aEEG backgrounds sleep-wake cycles (SWC) and NIRS values (TOI% and FTOE) were recorded. During the follow up their outcomes were assessed by using the Bayley Scales of Infant Development II.
Hypothermia changes the predictive value of early aEEG. Normalization of a baby's aEEG and the appearance of SWCs while being cooled occurs later. In our study one patient had normal aEEG background pattern at 80 and imminent SWC at 90 h after birth and still had normal Bayley scores at 24 months. Time to normal aEEG and SWC appearance should be carefully evaluated during the cooling period. NIRS values were different due to the clinical presentations of the patients.
Brain & development 07/2011; 34(4):280-6. · 1.74 Impact Factor
